Summit Trail Advisors’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.88M Buy
63,787
+5,282
+9% +$136K 0.02% 647
2026
Q1
$1.37M Sell
58,505
-20,763
-26% -$376K 0.02% 771
2025
Q4
$1.12M Sell
79,268
-17,206
-18% -$326K 0.02% 747
2025
Q3
$2.39M Buy
96,474
+38,700
+67% +$863K 0.03% 353
2025
Q2
$1.31M Buy
+57,774
New +$1.37M 0.02% 379
2018
Q1
Sell
-301
Closed -$10K 425
2017
Q4
$10K Buy
+301
New +$10.4K ﹤0.01% 1215

Other funds holding ACHC

Summit Trail Advisors's ACHC Position: Q2 2026 in Review

Summit Trail Advisors increased its Acadia Healthcare (ACHC) stake by 9% in Q2 2026, buying an estimated $136K and bringing the position to 63,787 shares worth $1.88M. The position accounts for 0.02% of the portfolio, ranked #647.

Summit Trail Advisors first reported a position in ACHC in Q4 2017 and has held it in 6 quarters since. The position peaked at $2.39M in Q3 2025. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Summit Trail Advisors held 63,787 shares of Acadia Healthcare worth $1.88M as of Q2 2026.
  • Summit Trail Advisors bought 5,282 Acadia Healthcare shares in Q2 2026, an estimated $136K.
  • Acadia Healthcare made up 0.02% of Summit Trail Advisors's portfolio in Q2 2026, its #647 holding.
  • Summit Trail Advisors first reported a position in Acadia Healthcare in Q4 2017 and has held it in 6 quarters since.
  • Summit Trail Advisors's Acadia Healthcare position peaked at $2.39M in Q3 2025.
  • 314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.